カテゴリー： 世界, 部品/材料, QYResearch

オンダンセトロンHCLの世界市場インサイト・予測（～2028年）

【英語タイトル】Global Ondansetron HCL Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX01821）・商品コード：QY22JLX01821
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：111
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、オンダンセトロンHCLのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にオンダンセトロンHCLの世界市場のxxx％を占める「純度≥99.5％」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「注射液」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
オンダンセトロンHCLの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのオンダンセトロンHCL市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

オンダンセトロンHCLのグローバル主要企業には、SUANFARMA、Dr. Reddy’s Laboratories、Teva、Anugraha Chemicals、Hikal、Dayaram Pharma、CTX、Cadila、SMS Pharmaceuticals、Fuan Pharmaceutical、Qilu Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

オンダンセトロンHCL市場は、種類と用途によって区分されます。世界のオンダンセトロンHCL市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
純度≥99.5％、純度≥99.9％

【用途別セグメント】
注射液、錠剤

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- オンダンセトロンHCL製品概要
- 種類別市場（純度≥99.5％、純度≥99.9％）
- 用途別市場（注射液、錠剤）
- 調査の目的
・エグゼクティブサマリー
- 世界のオンダンセトロンHCL販売量予測2017-2028
- 世界のオンダンセトロンHCL売上予測2017-2028
- オンダンセトロンHCLの地域別販売量
- オンダンセトロンHCLの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別オンダンセトロンHCL販売量
- 主要メーカー別オンダンセトロンHCL売上
- 主要メーカー別オンダンセトロンHCL価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（純度≥99.5％、純度≥99.9％）
- オンダンセトロンHCLの種類別販売量
- オンダンセトロンHCLの種類別売上
- オンダンセトロンHCLの種類別価格
・用途別市場規模（注射液、錠剤）
- オンダンセトロンHCLの用途別販売量
- オンダンセトロンHCLの用途別売上
- オンダンセトロンHCLの用途別価格
・北米市場
- 北米のオンダンセトロンHCL市場規模（種類別、用途別）
- 主要国別のオンダンセトロンHCL市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのオンダンセトロンHCL市場規模（種類別、用途別）
- 主要国別のオンダンセトロンHCL市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のオンダンセトロンHCL市場規模（種類別、用途別）
- 主要国別のオンダンセトロンHCL市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のオンダンセトロンHCL市場規模（種類別、用途別）
- 主要国別のオンダンセトロンHCL市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのオンダンセトロンHCL市場規模（種類別、用途別）
- 主要国別のオンダンセトロンHCL市場規模（トルコ、サウジアラビア）
・企業情報
SUANFARMA、Dr. Reddy’s Laboratories、Teva、Anugraha Chemicals、Hikal、Dayaram Pharma、CTX、Cadila、SMS Pharmaceuticals、Fuan Pharmaceutical、Qilu Pharmaceutical
・産業チェーン及び販売チャネル分析
- オンダンセトロンHCLの産業チェーン分析
- オンダンセトロンHCLの原材料
- オンダンセトロンHCLの生産プロセス
- オンダンセトロンHCLの販売及びマーケティング
- オンダンセトロンHCLの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- オンダンセトロンHCLの産業動向
- オンダンセトロンHCLのマーケットドライバー
- オンダンセトロンHCLの課題
- オンダンセトロンHCLの阻害要因
・主な調査結果

Market Analysis and Insights: Global Ondansetron HCL Market
Due to the COVID-19 pandemic, the global Ondansetron HCL market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥99.5% accounting for % of the Ondansetron HCL global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Injection Solution segment is altered to an % CAGR throughout this forecast period.
China Ondansetron HCL market size is valued at US$ million in 2021, while the US and Europe Ondansetron HCL are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Ondansetron HCL landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Ondansetron HCL include SUANFARMA, Dr. Reddy’s Laboratories, Teva, Anugraha Chemicals, Hikal, Dayaram Pharma, CTX, Cadila and SMS Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Ondansetron HCL capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Ondansetron HCL by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Ondansetron HCL Scope and Segment
Ondansetron HCL market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Ondansetron HCL market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity ≥99.5%
Purity ≥99.9%
Segment by Application
Injection Solution
Tablet
By Company
SUANFARMA
Dr. Reddy’s Laboratories
Teva
Anugraha Chemicals
Hikal
Dayaram Pharma
CTX
Cadila
SMS Pharmaceuticals
Fuan Pharmaceutical
Qilu Pharmaceutical
Production by Region
North America
Europe
China
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Ondansetron HCL Product Introduction
1.2 Market by Type
1.2.1 Global Ondansetron HCL Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity ≥99.5%
1.2.3 Purity ≥99.9%
1.3 Market by Application
1.3.1 Global Ondansetron HCL Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Injection Solution
1.3.3 Tablet
1.4 Study Objectives
1.5 Years Considered
2 Global Ondansetron HCL Production
2.1 Global Ondansetron HCL Production Capacity (2017-2028)
2.2 Global Ondansetron HCL Production by Region: 2017 VS 2021 VS 2028
2.3 Global Ondansetron HCL Production by Region
2.3.1 Global Ondansetron HCL Historic Production by Region (2017-2022)
2.3.2 Global Ondansetron HCL Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 India
3 Global Ondansetron HCL Sales in Volume & Value Estimates and Forecasts
3.1 Global Ondansetron HCL Sales Estimates and Forecasts 2017-2028
3.2 Global Ondansetron HCL Revenue Estimates and Forecasts 2017-2028
3.3 Global Ondansetron HCL Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Ondansetron HCL Sales by Region
3.4.1 Global Ondansetron HCL Sales by Region (2017-2022)
3.4.2 Global Sales Ondansetron HCL by Region (2023-2028)
3.5 Global Ondansetron HCL Revenue by Region
3.5.1 Global Ondansetron HCL Revenue by Region (2017-2022)
3.5.2 Global Ondansetron HCL Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Ondansetron HCL Production Capacity by Manufacturers
4.2 Global Ondansetron HCL Sales by Manufacturers
4.2.1 Global Ondansetron HCL Sales by Manufacturers (2017-2022)
4.2.2 Global Ondansetron HCL Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Ondansetron HCL in 2021
4.3 Global Ondansetron HCL Revenue by Manufacturers
4.3.1 Global Ondansetron HCL Revenue by Manufacturers (2017-2022)
4.3.2 Global Ondansetron HCL Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Ondansetron HCL Revenue in 2021
4.4 Global Ondansetron HCL Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Ondansetron HCL Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Ondansetron HCL Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Ondansetron HCL Sales by Type
5.1.1 Global Ondansetron HCL Historical Sales by Type (2017-2022)
5.1.2 Global Ondansetron HCL Forecasted Sales by Type (2023-2028)
5.1.3 Global Ondansetron HCL Sales Market Share by Type (2017-2028)
5.2 Global Ondansetron HCL Revenue by Type
5.2.1 Global Ondansetron HCL Historical Revenue by Type (2017-2022)
5.2.2 Global Ondansetron HCL Forecasted Revenue by Type (2023-2028)
5.2.3 Global Ondansetron HCL Revenue Market Share by Type (2017-2028)
5.3 Global Ondansetron HCL Price by Type
5.3.1 Global Ondansetron HCL Price by Type (2017-2022)
5.3.2 Global Ondansetron HCL Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Ondansetron HCL Sales by Application
6.1.1 Global Ondansetron HCL Historical Sales by Application (2017-2022)
6.1.2 Global Ondansetron HCL Forecasted Sales by Application (2023-2028)
6.1.3 Global Ondansetron HCL Sales Market Share by Application (2017-2028)
6.2 Global Ondansetron HCL Revenue by Application
6.2.1 Global Ondansetron HCL Historical Revenue by Application (2017-2022)
6.2.2 Global Ondansetron HCL Forecasted Revenue by Application (2023-2028)
6.2.3 Global Ondansetron HCL Revenue Market Share by Application (2017-2028)
6.3 Global Ondansetron HCL Price by Application
6.3.1 Global Ondansetron HCL Price by Application (2017-2022)
6.3.2 Global Ondansetron HCL Price Forecast by Application (2023-2028)
7 North America
7.1 North America Ondansetron HCL Market Size by Type
7.1.1 North America Ondansetron HCL Sales by Type (2017-2028)
7.1.2 North America Ondansetron HCL Revenue by Type (2017-2028)
7.2 North America Ondansetron HCL Market Size by Application
7.2.1 North America Ondansetron HCL Sales by Application (2017-2028)
7.2.2 North America Ondansetron HCL Revenue by Application (2017-2028)
7.3 North America Ondansetron HCL Sales by Country
7.3.1 North America Ondansetron HCL Sales by Country (2017-2028)
7.3.2 North America Ondansetron HCL Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Ondansetron HCL Market Size by Type
8.1.1 Europe Ondansetron HCL Sales by Type (2017-2028)
8.1.2 Europe Ondansetron HCL Revenue by Type (2017-2028)
8.2 Europe Ondansetron HCL Market Size by Application
8.2.1 Europe Ondansetron HCL Sales by Application (2017-2028)
8.2.2 Europe Ondansetron HCL Revenue by Application (2017-2028)
8.3 Europe Ondansetron HCL Sales by Country
8.3.1 Europe Ondansetron HCL Sales by Country (2017-2028)
8.3.2 Europe Ondansetron HCL Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Ondansetron HCL Market Size by Type
9.1.1 Asia Pacific Ondansetron HCL Sales by Type (2017-2028)
9.1.2 Asia Pacific Ondansetron HCL Revenue by Type (2017-2028)
9.2 Asia Pacific Ondansetron HCL Market Size by Application
9.2.1 Asia Pacific Ondansetron HCL Sales by Application (2017-2028)
9.2.2 Asia Pacific Ondansetron HCL Revenue by Application (2017-2028)
9.3 Asia Pacific Ondansetron HCL Sales by Region
9.3.1 Asia Pacific Ondansetron HCL Sales by Region (2017-2028)
9.3.2 Asia Pacific Ondansetron HCL Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Ondansetron HCL Market Size by Type
10.1.1 Latin America Ondansetron HCL Sales by Type (2017-2028)
10.1.2 Latin America Ondansetron HCL Revenue by Type (2017-2028)
10.2 Latin America Ondansetron HCL Market Size by Application
10.2.1 Latin America Ondansetron HCL Sales by Application (2017-2028)
10.2.2 Latin America Ondansetron HCL Revenue by Application (2017-2028)
10.3 Latin America Ondansetron HCL Sales by Country
10.3.1 Latin America Ondansetron HCL Sales by Country (2017-2028)
10.3.2 Latin America Ondansetron HCL Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Ondansetron HCL Market Size by Type
11.1.1 Middle East and Africa Ondansetron HCL Sales by Type (2017-2028)
11.1.2 Middle East and Africa Ondansetron HCL Revenue by Type (2017-2028)
11.2 Middle East and Africa Ondansetron HCL Market Size by Application
11.2.1 Middle East and Africa Ondansetron HCL Sales by Application (2017-2028)
11.2.2 Middle East and Africa Ondansetron HCL Revenue by Application (2017-2028)
11.3 Middle East and Africa Ondansetron HCL Sales by Country
11.3.1 Middle East and Africa Ondansetron HCL Sales by Country (2017-2028)
11.3.2 Middle East and Africa Ondansetron HCL Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 SUANFARMA
12.1.1 SUANFARMA Corporation Information
12.1.2 SUANFARMA Overview
12.1.3 SUANFARMA Ondansetron HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 SUANFARMA Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 SUANFARMA Recent Developments
12.2 Dr. Reddy’s Laboratories
12.2.1 Dr. Reddy’s Laboratories Corporation Information
12.2.2 Dr. Reddy’s Laboratories Overview
12.2.3 Dr. Reddy’s Laboratories Ondansetron HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Dr. Reddy’s Laboratories Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Dr. Reddy’s Laboratories Recent Developments
12.3 Teva
12.3.1 Teva Corporation Information
12.3.2 Teva Overview
12.3.3 Teva Ondansetron HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Teva Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Teva Recent Developments
12.4 Anugraha Chemicals
12.4.1 Anugraha Chemicals Corporation Information
12.4.2 Anugraha Chemicals Overview
12.4.3 Anugraha Chemicals Ondansetron HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Anugraha Chemicals Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Anugraha Chemicals Recent Developments
12.5 Hikal
12.5.1 Hikal Corporation Information
12.5.2 Hikal Overview
12.5.3 Hikal Ondansetron HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Hikal Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Hikal Recent Developments
12.6 Dayaram Pharma
12.6.1 Dayaram Pharma Corporation Information
12.6.2 Dayaram Pharma Overview
12.6.3 Dayaram Pharma Ondansetron HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Dayaram Pharma Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Dayaram Pharma Recent Developments
12.7 CTX
12.7.1 CTX Corporation Information
12.7.2 CTX Overview
12.7.3 CTX Ondansetron HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 CTX Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 CTX Recent Developments
12.8 Cadila
12.8.1 Cadila Corporation Information
12.8.2 Cadila Overview
12.8.3 Cadila Ondansetron HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Cadila Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Cadila Recent Developments
12.9 SMS Pharmaceuticals
12.9.1 SMS Pharmaceuticals Corporation Information
12.9.2 SMS Pharmaceuticals Overview
12.9.3 SMS Pharmaceuticals Ondansetron HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 SMS Pharmaceuticals Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 SMS Pharmaceuticals Recent Developments
12.10 Fuan Pharmaceutical
12.10.1 Fuan Pharmaceutical Corporation Information
12.10.2 Fuan Pharmaceutical Overview
12.10.3 Fuan Pharmaceutical Ondansetron HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Fuan Pharmaceutical Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Fuan Pharmaceutical Recent Developments
12.11 Qilu Pharmaceutical
12.11.1 Qilu Pharmaceutical Corporation Information
12.11.2 Qilu Pharmaceutical Overview
12.11.3 Qilu Pharmaceutical Ondansetron HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Qilu Pharmaceutical Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Qilu Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Ondansetron HCL Industry Chain Analysis
13.2 Ondansetron HCL Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Ondansetron HCL Production Mode & Process
13.4 Ondansetron HCL Sales and Marketing
13.4.1 Ondansetron HCL Sales Channels
13.4.2 Ondansetron HCL Distributors
13.5 Ondansetron HCL Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Ondansetron HCL Industry Trends
14.2 Ondansetron HCL Market Drivers
14.3 Ondansetron HCL Market Challenges
14.4 Ondansetron HCL Market Restraints
15 Key Finding in The Global Ondansetron HCL Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Ondansetron HCL Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Purity ≥99.5%
Table 3. Major Manufacturers of Purity ≥99.9%
Table 4. Global Ondansetron HCL Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Ondansetron HCL Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 6. Global Ondansetron HCL Production by Region (2017-2022) & (Tons)
Table 7. Global Ondansetron HCL Production Market Share by Region (2017-2022)
Table 8. Global Ondansetron HCL Production by Region (2023-2028) & (Tons)
Table 9. Global Ondansetron HCL Production Market Share by Region (2023-2028)
Table 10. Global Ondansetron HCL Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Ondansetron HCL Sales by Region (2017-2022) & (Tons)
Table 12. Global Ondansetron HCL Sales Market Share by Region (2017-2022)
Table 13. Global Ondansetron HCL Sales by Region (2023-2028) & (Tons)
Table 14. Global Ondansetron HCL Sales Market Share by Region (2023-2028)
Table 15. Global Ondansetron HCL Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Ondansetron HCL Revenue Market Share by Region (2017-2022)
Table 17. Global Ondansetron HCL Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Ondansetron HCL Revenue Market Share by Region (2023-2028)
Table 19. Global Ondansetron HCL Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 20. Global Ondansetron HCL Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Ondansetron HCL Sales by Manufacturers (2017-2022) & (Tons)
Table 22. Global Ondansetron HCL Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Ondansetron HCL Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Ondansetron HCL Revenue Share by Manufacturers (2017-2022)
Table 25. Ondansetron HCL Price by Manufacturers 2017-2022 (US$/Ton)
Table 26. Global Ondansetron HCL Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Ondansetron HCL by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ondansetron HCL as of 2021)
Table 28. Ondansetron HCL Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Ondansetron HCL Product Offered
Table 30. Date of Manufacturers Enter into Ondansetron HCL Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Ondansetron HCL Sales by Type (2017-2022) & (Tons)
Table 33. Global Ondansetron HCL Sales by Type (2023-2028) & (Tons)
Table 34. Global Ondansetron HCL Sales Share by Type (2017-2022)
Table 35. Global Ondansetron HCL Sales Share by Type (2023-2028)
Table 36. Global Ondansetron HCL Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Ondansetron HCL Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Ondansetron HCL Revenue Share by Type (2017-2022)
Table 39. Global Ondansetron HCL Revenue Share by Type (2023-2028)
Table 40. Ondansetron HCL Price by Type (2017-2022) & (US$/Ton)
Table 41. Global Ondansetron HCL Price Forecast by Type (2023-2028) & (US$/Ton)
Table 42. Global Ondansetron HCL Sales by Application (2017-2022) & (Tons)
Table 43. Global Ondansetron HCL Sales by Application (2023-2028) & (Tons)
Table 44. Global Ondansetron HCL Sales Share by Application (2017-2022)
Table 45. Global Ondansetron HCL Sales Share by Application (2023-2028)
Table 46. Global Ondansetron HCL Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Ondansetron HCL Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Ondansetron HCL Revenue Share by Application (2017-2022)
Table 49. Global Ondansetron HCL Revenue Share by Application (2023-2028)
Table 50. Ondansetron HCL Price by Application (2017-2022) & (US$/Ton)
Table 51. Global Ondansetron HCL Price Forecast by Application (2023-2028) & (US$/Ton)
Table 52. North America Ondansetron HCL Sales by Type (2017-2022) & (Tons)
Table 53. North America Ondansetron HCL Sales by Type (2023-2028) & (Tons)
Table 54. North America Ondansetron HCL Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Ondansetron HCL Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Ondansetron HCL Sales by Application (2017-2022) & (Tons)
Table 57. North America Ondansetron HCL Sales by Application (2023-2028) & (Tons)
Table 58. North America Ondansetron HCL Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Ondansetron HCL Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Ondansetron HCL Sales by Country (2017-2022) & (Tons)
Table 61. North America Ondansetron HCL Sales by Country (2023-2028) & (Tons)
Table 62. North America Ondansetron HCL Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Ondansetron HCL Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Ondansetron HCL Sales by Type (2017-2022) & (Tons)
Table 65. Europe Ondansetron HCL Sales by Type (2023-2028) & (Tons)
Table 66. Europe Ondansetron HCL Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Ondansetron HCL Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Ondansetron HCL Sales by Application (2017-2022) & (Tons)
Table 69. Europe Ondansetron HCL Sales by Application (2023-2028) & (Tons)
Table 70. Europe Ondansetron HCL Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Ondansetron HCL Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Ondansetron HCL Sales by Country (2017-2022) & (Tons)
Table 73. Europe Ondansetron HCL Sales by Country (2023-2028) & (Tons)
Table 74. Europe Ondansetron HCL Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Ondansetron HCL Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Ondansetron HCL Sales by Type (2017-2022) & (Tons)
Table 77. Asia Pacific Ondansetron HCL Sales by Type (2023-2028) & (Tons)
Table 78. Asia Pacific Ondansetron HCL Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Ondansetron HCL Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Ondansetron HCL Sales by Application (2017-2022) & (Tons)
Table 81. Asia Pacific Ondansetron HCL Sales by Application (2023-2028) & (Tons)
Table 82. Asia Pacific Ondansetron HCL Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Ondansetron HCL Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Ondansetron HCL Sales by Region (2017-2022) & (Tons)
Table 85. Asia Pacific Ondansetron HCL Sales by Region (2023-2028) & (Tons)
Table 86. Asia Pacific Ondansetron HCL Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Ondansetron HCL Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Ondansetron HCL Sales by Type (2017-2022) & (Tons)
Table 89. Latin America Ondansetron HCL Sales by Type (2023-2028) & (Tons)
Table 90. Latin America Ondansetron HCL Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Ondansetron HCL Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Ondansetron HCL Sales by Application (2017-2022) & (Tons)
Table 93. Latin America Ondansetron HCL Sales by Application (2023-2028) & (Tons)
Table 94. Latin America Ondansetron HCL Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Ondansetron HCL Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Ondansetron HCL Sales by Country (2017-2022) & (Tons)
Table 97. Latin America Ondansetron HCL Sales by Country (2023-2028) & (Tons)
Table 98. Latin America Ondansetron HCL Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Ondansetron HCL Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Ondansetron HCL Sales by Type (2017-2022) & (Tons)
Table 101. Middle East and Africa Ondansetron HCL Sales by Type (2023-2028) & (Tons)
Table 102. Middle East and Africa Ondansetron HCL Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Ondansetron HCL Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Ondansetron HCL Sales by Application (2017-2022) & (Tons)
Table 105. Middle East and Africa Ondansetron HCL Sales by Application (2023-2028) & (Tons)
Table 106. Middle East and Africa Ondansetron HCL Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Ondansetron HCL Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Ondansetron HCL Sales by Country (2017-2022) & (Tons)
Table 109. Middle East and Africa Ondansetron HCL Sales by Country (2023-2028) & (Tons)
Table 110. Middle East and Africa Ondansetron HCL Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Ondansetron HCL Revenue by Country (2023-2028) & (US$ Million)
Table 112. SUANFARMA Corporation Information
Table 113. SUANFARMA Description and Major Businesses
Table 114. SUANFARMA Ondansetron HCL Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 115. SUANFARMA Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. SUANFARMA Recent Development
Table 117. Dr. Reddy’s Laboratories Corporation Information
Table 118. Dr. Reddy’s Laboratories Description and Major Businesses
Table 119. Dr. Reddy’s Laboratories Ondansetron HCL Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 120. Dr. Reddy’s Laboratories Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Dr. Reddy’s Laboratories Recent Development
Table 122. Teva Corporation Information
Table 123. Teva Description and Major Businesses
Table 124. Teva Ondansetron HCL Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 125. Teva Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Teva Recent Development
Table 127. Anugraha Chemicals Corporation Information
Table 128. Anugraha Chemicals Description and Major Businesses
Table 129. Anugraha Chemicals Ondansetron HCL Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 130. Anugraha Chemicals Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Anugraha Chemicals Recent Development
Table 132. Hikal Corporation Information
Table 133. Hikal Description and Major Businesses
Table 134. Hikal Ondansetron HCL Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 135. Hikal Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Hikal Recent Development
Table 137. Dayaram Pharma Corporation Information
Table 138. Dayaram Pharma Description and Major Businesses
Table 139. Dayaram Pharma Ondansetron HCL Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 140. Dayaram Pharma Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Dayaram Pharma Recent Development
Table 142. CTX Corporation Information
Table 143. CTX Description and Major Businesses
Table 144. CTX Ondansetron HCL Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 145. CTX Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. CTX Recent Development
Table 147. Cadila Corporation Information
Table 148. Cadila Description and Major Businesses
Table 149. Cadila Ondansetron HCL Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 150. Cadila Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Cadila Recent Development
Table 152. SMS Pharmaceuticals Corporation Information
Table 153. SMS Pharmaceuticals Description and Major Businesses
Table 154. SMS Pharmaceuticals Ondansetron HCL Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 155. SMS Pharmaceuticals Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. SMS Pharmaceuticals Recent Development
Table 157. Fuan Pharmaceutical Corporation Information
Table 158. Fuan Pharmaceutical Description and Major Businesses
Table 159. Fuan Pharmaceutical Ondansetron HCL Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 160. Fuan Pharmaceutical Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Fuan Pharmaceutical Recent Development
Table 162. Qilu Pharmaceutical Corporation Information
Table 163. Qilu Pharmaceutical Description and Major Businesses
Table 164. Qilu Pharmaceutical Ondansetron HCL Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 165. Qilu Pharmaceutical Ondansetron HCL Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Qilu Pharmaceutical Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Ondansetron HCL Distributors List
Table 170. Ondansetron HCL Customers List
Table 171. Ondansetron HCL Market Trends
Table 172. Ondansetron HCL Market Drivers
Table 173. Ondansetron HCL Market Challenges
Table 174. Ondansetron HCL Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Ondansetron HCL Product Picture
Figure 2. Global Ondansetron HCL Market Share by Type in 2021 & 2028
Figure 3. Purity ≥99.5% Product Picture
Figure 4. Purity ≥99.9% Product Picture
Figure 5. Global Ondansetron HCL Market Share by Application in 2021 & 2028
Figure 6. Injection Solution
Figure 7. Tablet
Figure 8. Ondansetron HCL Report Years Considered
Figure 9. Global Ondansetron HCL Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 10. Global Ondansetron HCL Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 11. Global Ondansetron HCL Production Market Share by Region (2017-2022)
Figure 12. Global Ondansetron HCL Production Market Share by Region (2023-2028)
Figure 13. Ondansetron HCL Production Growth Rate in North America (2017-2028) & (Tons)
Figure 14. Ondansetron HCL Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 15. Ondansetron HCL Production Growth Rate in China (2017-2028) & (Tons)
Figure 16. Ondansetron HCL Production Growth Rate in India (2017-2028) & (Tons)
Figure 17. Global Ondansetron HCL Sales 2017-2028 (Tons)
Figure 18. Global Ondansetron HCL Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 19. Global Ondansetron HCL Revenue 2017-2028 (US$ Million)
Figure 20. Global Ondansetron HCL Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 21. Global Ondansetron HCL Sales Market Share by Region (2017-2022)
Figure 22. Global Ondansetron HCL Sales Market Share by Region (2023-2028)
Figure 23. North America Ondansetron HCL Sales YoY (2017-2028) & (Tons)
Figure 24. North America Ondansetron HCL Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Europe Ondansetron HCL Sales YoY (2017-2028) & (Tons)
Figure 26. Europe Ondansetron HCL Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Ondansetron HCL Sales YoY (2017-2028) & (Tons)
Figure 28. Asia-Pacific Ondansetron HCL Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Latin America Ondansetron HCL Sales YoY (2017-2028) & (Tons)
Figure 30. Latin America Ondansetron HCL Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Middle East & Africa Ondansetron HCL Sales YoY (2017-2028) & (Tons)
Figure 32. Middle East & Africa Ondansetron HCL Revenue YoY (2017-2028) & (US$ Million)
Figure 33. The Ondansetron HCL Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 34. The Top 5 and 10 Largest Manufacturers of Ondansetron HCL in the World: Market Share by Ondansetron HCL Revenue in 2021
Figure 35. Ondansetron HCL Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 36. Global Ondansetron HCL Sales Market Share by Type (2017-2028)
Figure 37. Global Ondansetron HCL Revenue Market Share by Type (2017-2028)
Figure 38. Global Ondansetron HCL Sales Market Share by Application (2017-2028)
Figure 39. Global Ondansetron HCL Revenue Market Share by Application (2017-2028)
Figure 40. North America Ondansetron HCL Sales Market Share by Type (2017-2028)
Figure 41. North America Ondansetron HCL Revenue Market Share by Type (2017-2028)
Figure 42. North America Ondansetron HCL Sales Market Share by Application (2017-2028)
Figure 43. North America Ondansetron HCL Revenue Market Share by Application (2017-2028)
Figure 44. North America Ondansetron HCL Sales Share by Country (2017-2028)
Figure 45. North America Ondansetron HCL Revenue Share by Country (2017-2028)
Figure 46. United States Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 47. Canada Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 48. Europe Ondansetron HCL Sales Market Share by Type (2017-2028)
Figure 49. Europe Ondansetron HCL Revenue Market Share by Type (2017-2028)
Figure 50. Europe Ondansetron HCL Sales Market Share by Application (2017-2028)
Figure 51. Europe Ondansetron HCL Revenue Market Share by Application (2017-2028)
Figure 52. Europe Ondansetron HCL Sales Share by Country (2017-2028)
Figure 53. Europe Ondansetron HCL Revenue Share by Country (2017-2028)
Figure 54. Germany Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 55. France Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 56. U.K. Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 57. Italy Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 58. Russia Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 59. Asia Pacific Ondansetron HCL Sales Market Share by Type (2017-2028)
Figure 60. Asia Pacific Ondansetron HCL Revenue Market Share by Type (2017-2028)
Figure 61. Asia Pacific Ondansetron HCL Sales Market Share by Application (2017-2028)
Figure 62. Asia Pacific Ondansetron HCL Revenue Market Share by Application (2017-2028)
Figure 63. Asia Pacific Ondansetron HCL Sales Share by Region (2017-2028)
Figure 64. Asia Pacific Ondansetron HCL Revenue Share by Region (2017-2028)
Figure 65. China Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 66. Japan Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 67. South Korea Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 68. India Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 69. Australia Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 70. China Taiwan Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 71. Indonesia Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 72. Thailand Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 73. Malaysia Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Ondansetron HCL Sales Market Share by Type (2017-2028)
Figure 75. Latin America Ondansetron HCL Revenue Market Share by Type (2017-2028)
Figure 76. Latin America Ondansetron HCL Sales Market Share by Application (2017-2028)
Figure 77. Latin America Ondansetron HCL Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Ondansetron HCL Sales Share by Country (2017-2028)
Figure 79. Latin America Ondansetron HCL Revenue Share by Country (2017-2028)
Figure 80. Mexico Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 83. Colombia Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 84. Middle East and Africa Ondansetron HCL Sales Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Ondansetron HCL Revenue Market Share by Type (2017-2028)
Figure 86. Middle East and Africa Ondansetron HCL Sales Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Ondansetron HCL Revenue Market Share by Application (2017-2028)
Figure 88. Middle East and Africa Ondansetron HCL Sales Share by Country (2017-2028)
Figure 89. Middle East and Africa Ondansetron HCL Revenue Share by Country (2017-2028)
Figure 90. Turkey Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 91. Saudi Arabia Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 92. UAE Ondansetron HCL Revenue (2017-2028) & (US$ Million)
Figure 93. Ondansetron HCL Value Chain
Figure 94. Ondansetron HCL Production Process
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed


★調査レポート[オンダンセトロンHCLの世界市場インサイト・予測（～2028年）] (コード：QY22JLX01821)販売に関する免責事項を必ずご確認ください。
★調査レポート[オンダンセトロンHCLの世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のオンダンセトロン塩酸塩注射剤市場2022年：2ml /バイアル、20ml/バイアル
  • 5HT3受容体拮抗薬の世界市場インサイト・予測（～2028年）
  • 5-ヒドロキシトリプタミン受容体アゴニストの世界市場インサイト・予測（～2028年）
  • グリセリンエトキシレートの世界市場インサイト・予測（～2028年）
  • 高純度MDIの世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆